Discrimination of Dysplastic Nevi from Common Melanocytic Nevi by Cellular and Molecular Criteria

    Hiroshi Mitsui, Felix Kiecker, Avner Shemer, Maria Vittoria Cannizzaro, Claire Q. Wang, Nicholas Gulati, Hanako Ohmatsu, Kejal R. Shah, Patricia Gilleaudeau, Mary Sullivan‐Whalen, Inna Cueto, N. Scott McNutt, Mayte Suárez‐Fariñas, James G. Krueger
    TLDR Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.
    The study differentiated dysplastic nevi (DNs) from common melanocytic nevi (CMNs) using cellular and molecular criteria, involving 5 CMNs, 7 DNs, and 6 normal skin samples. Researchers identified 111 differentially expressed probesets, with DNs showing increased expression of hair follicle-related genes and distinct immune microenvironments. Key findings included upregulation of genes like KRT25 and TCHH, and immune-related cytokines such as IL12B and IFNγ. DUSP3 was highlighted as a key gene distinguishing DNs from CMNs. The study concluded that DNs are distinct entities with unique gene expression profiles, suggesting they are not merely subtypes of CMNs. Further research with larger sample sizes was recommended.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    2 / 2 results

      community Hair loss research is a money grab

      in Chat  217 upvotes 2 weeks ago
      Hair loss is linked to DHT, with treatments like finasteride and minoxidil being common but not definitive. Economic interests influence research, and there is potential for new treatments like PP405 and RU58841.

    Similar Research

    5 / 1000+ results